Atlas Trials

START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC

Clinical trial NCT05209243 · RECRUITING

Trial details

NCT number
NCT05209243
Sponsor
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostate CancerStereotactic Body Radiation Therapy
Start date
2023-01-26
Primary completion
2025-01-01
Enrollment
266

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.